Colon Cancer
Conditions
Interventions
Colon cancer group:Nil
Ulcerative colitis group:Nil
Colorectal Adenomas group:Nil
Sponsors
Shanghai Tenth People's Hospital Affiliated to Tongji University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Ages Eligible for Study: 25 Years to 75 Years (Adult, Older Adult); Sexes Eligible for Study: All (2) Diagnosis of Adenoma, ulcerative colitis or colon cancer; (3) Eastern Cooperative Oncology Group (ECOG) Performance Status (PS):0-1; (4) Able to understand and willing to sign written informed consent form; (5) There is a supervisor who can be contacted regularly to report the subject's clinical / mental status.
Exclusion criteria
Exclusion criteria: (1) Subjects with active viral or bacterial infections that cannot be controlled by anti infective therapy; (2) Known history of human immunodeficiency virus infection or current chronic or active hepatitis B or C infection requiring treatment with antiviral therapy; (3) Subjects with autoimmune diseases or extremely low immunity, or other diseases requiring systemic immunosuppressive drugs or hormones; (4) Subjects with any other serious diseases The researchers believe that it may affect the treatment, follow-up or evaluation of patients. Including any uncontrollable neurological, psychiatric, immune regulatory, metabolic and infectious diseases; (5) Women who are pregnancy or breast-feeding; (6) Antibacterial or probiotic treatment 4 weeks before enrollment; (7) Subjects with history of alcohol or drug abuse within 3 months before enrollment; (8) Participated in any experimental drug program in the past 12 weeks; (9) Used immunosuppressive agents or chemotherapy in the past two years; (10) Ineligible patients according to the investigator's judgement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Single-cell Sequencing; | — |
Countries
China
Contacts
Public ContactHuanlong Qin
Shanghai Tenth People's Hospital Affiliated to Tongji University
Outcome results
None listed